Pepper Hamilton on midmarket pharma, healthcare deals (The Deal)

Knowledge Centers

Pepper Hamilton on midmarket pharma, healthcare deals

020810 pepper hamilton MM health 346 fix bw2.gif

Pharma and healthcare deals seem to have remained recession-proof. As the economic environment improves, Pepper Hamilton LLP partners Christopher Miller and John Jones believe dealmaking in the sector is likely to pick up. In this podcast sponsored by Pepper Hamilton, the two discuss the larger issues facing the industry and how they will affect dealmaking.

Presented by

©Copyright 2011, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.

Music 2.0

The music business wrestles with a fluid, dynamic ecosystem dominated by fans, artists and new technologies.

Not so dumb pipes

Customers of Netflix and other high-flying Internet businesses may be facing higher fees for online usage. Look out below.

Is there life after Stockman?

Heartland holdover Dan Tredwell tries to salvage assets, with hopes of starting anew.

Deal and its critics

We didn't do anything wrong, and the people who did it no longer work here.

Powers, patents and parasites

Matthew Powers leaves Weil to strike out on his own, reflecting an increasingly complex patent environment.

Goodbye GAAP?

As the SEC considers adopting international accounting standards, the industry waits and worries.

WEBCAST

See our complete 2011 Webcast Series and then join us for the 60-minute in-depth conversation on each topic. These webcasts will be moderated by a senior journalist from The Deal magazine, and they will have the ability to take live audience questions throughout each webcast event.

WEBCAST

The August 18th discussion will focus on how companies' due diligence processes are evolving and how these techniques are impacting the flow of M&A.

WEBCAST

A replay of a talk among dealmakers on European acquirers making transactions across their borders.